These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 2756879

  • 1. Comparison of the effects of pindolol and propranolol on exercise performance in young men with systemic hypertension.
    Martin NB, Broeder CE, Thomas EL, Wambsgans KC, Scruggs KD, Jesek JK, Hofman Z, Wilmore JH.
    Am J Cardiol; 1989 Aug 01; 64(5):343-7. PubMed ID: 2756879
    [Abstract] [Full Text] [Related]

  • 2. Stroke volume during submaximal exercise in endurance-trained normotensive subjects and in untrained hypertensive subjects with beta blockade (propranolol and pindolol).
    Scruggs KD, Martin NB, Broeder CE, Hofman Z, Thomas EL, Wambsgans KC, Wilmore JH.
    Am J Cardiol; 1991 Feb 15; 67(5):416-21. PubMed ID: 1994667
    [Abstract] [Full Text] [Related]

  • 3. Exercise haemodynamic effects of beta-blockade and intrinsic sympathomimetic activity.
    Ades PA, Wolfel EE, Hiatt WR, Fee C, Rolfs R, Brammell HL, Horwitz LD.
    Eur J Clin Pharmacol; 1989 Feb 15; 36(1):5-10. PubMed ID: 2917588
    [Abstract] [Full Text] [Related]

  • 4. Changes in plasma free fatty acids and glycerols during prolonged exercise in trained and hypertensive persons taking propranolol and pindolol.
    Jesek JK, Martin NB, Broeder CE, Thomas EL, Wambsgans KC, Hofman Z, Ivy JL, Wilmore JH.
    Am J Cardiol; 1990 Dec 01; 66(19):1336-41. PubMed ID: 2244564
    [Abstract] [Full Text] [Related]

  • 5. Comparison of the effects of pindolol and propranolol on exercise performance in patients with angina pectoris.
    Magder S, Sami M, Ripley R, Lisbona R.
    Am J Cardiol; 1987 Jun 01; 59(15):1289-94. PubMed ID: 3591681
    [Abstract] [Full Text] [Related]

  • 6. Effects of propranolol and pindolol on cardiac output during extended periods of low-intensity physical activity.
    Broeder CE, Thomas EL, Martin NB, Hofman Z, Jesek JK, Scruggs KD, Wambsgans KC, Wilmore JH.
    Am J Cardiol; 1993 Nov 15; 72(15):1188-95. PubMed ID: 8237812
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effect of intrinsic sympathomimetic activity on the ability of hypertensive patients to derive a cardiorespiratory training effect during chronic beta-blockade.
    Duncan JJ, Vaandrager H, Farr JE, Kohl HW, Gordon NF.
    Am J Hypertens; 1990 Apr 15; 3(4):302-6. PubMed ID: 1971751
    [Abstract] [Full Text] [Related]

  • 9. Ambulatory blood pressure during once-daily randomised double-blind administration of atenolol, metoprolol, pindolol, and slow-release propranolol.
    Floras JS, Jones JV, Hassan MO, Sleight P.
    Br Med J (Clin Res Ed); 1982 Nov 13; 285(6352):1387-92. PubMed ID: 6814568
    [Abstract] [Full Text] [Related]

  • 10. Role of the Frank-Starling mechanism in maintaining cardiac output during increasing levels of treadmill exercise in beta-blocked normal men.
    Bevilacqua M, Savonitto S, Bosisio E, Chebat E, Bertora PL, Sardina M, Norbiato G.
    Am J Cardiol; 1989 Apr 01; 63(12):853-7. PubMed ID: 2564724
    [Abstract] [Full Text] [Related]

  • 11. Long-term antihypertensive therapy with beta-blockers: submaximal exercise capacity and metabolic effects during exercise.
    van Baak MA, Böhm RO, Arends BG, van Hooff ME, Rahn KH.
    Int J Sports Med; 1987 Oct 01; 8(5):342-7. PubMed ID: 2890591
    [Abstract] [Full Text] [Related]

  • 12. Acute hemodynamic effects of pindolol and propranolol in patients with dilated cardiomyopathy: relevance of intrinsic sympathomimetic activity.
    Shanes JG, Wolfkiel C, Ghali J, Dierenfeldt BJ, Kondos GT, Bauman JL.
    Am Heart J; 1988 Nov 01; 116(5 Pt 1):1268-75. PubMed ID: 3189143
    [Abstract] [Full Text] [Related]

  • 13. A comparison of the effects of beta-blockers with and without intrinsic sympathomimetic activity on hemodynamics and left ventricular function at rest and during exercise in patients with coronary artery disease.
    Choong CY, Roubin GS, Harris PJ, Tokuyasu Y, Shen WF, Bautovich GJ, Kelly DT.
    J Cardiovasc Pharmacol; 1986 Nov 01; 8(3):441-8. PubMed ID: 2425156
    [Abstract] [Full Text] [Related]

  • 14. Clinical pharmacology of pindolol.
    Aellig WH.
    Am Heart J; 1982 Aug 01; 104(2 Pt 2):346-56. PubMed ID: 6125094
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Treatment of angina pectoris with pindolol: the significance of intrinsic sympathomimetic activity of beta blockers.
    Kostis JB, Frishman W, Hosler MH, Thorsen NL, Gonasun L, Weinstein J.
    Am Heart J; 1982 Aug 01; 104(2 Pt 2):496-504. PubMed ID: 7102536
    [Abstract] [Full Text] [Related]

  • 17. Pindolol and propranolol in patients with angina pectoris and normal or near-normal ventricular function. Lack of influence of intrinsic sympathomimetic activity on global and segmental left ventricular function assessed by radionuclide ventriculography.
    Manyari DE, Kostuk WJ, Carruthers SG, Johnston DJ, Purves P.
    Am J Cardiol; 1983 Feb 01; 51(3):427-33. PubMed ID: 6401908
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Blood pressure reactivity in the evaluation of resting blood pressure and mood responses to pindolol and propranolol in hypertensive patients.
    Potempa KM, Fogg LF, Fish AF, Kravitz HM.
    Heart Lung; 1993 Feb 01; 22(5):383-91. PubMed ID: 8226001
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.